Results 81 to 90 of about 3,331,814 (239)

Glaucoma: role of neuroprotective agents

International Journal of Basic & Clinical Pharmacology, 2014
Glaucoma is an optic neuropathy, considered as the second leading cause of blindness worldwide. Glaucoma is characterized by selective death of retinal ganglion cells (RGC) and a progressive loss of vision. Elevated intraocular pressure (IOP) is one of the most important risk factors for developing glaucoma and hence we mainly focus on lowering IOP to ...
Parul Singh, Achyut N. Pandey, Prabha Sharma, Ameeta Kaul   +3 more
openaire   +2 more sources

Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Clinical Ophthalmology, 2023
Hannah Khan,1 Aamir A Aziz,1 Humza Sulahria,2 Huma Khan,2 Abrahim Ahmed,3 Netan Choudhry,4– 7 Raja Narayanan,8,9 Carl Danzig,10 Arshad M Khanani1,2 1University of Nevada, Reno School of Medicine, Reno, NV, USA; 2Sierra Eye Associates, Reno, NV, USA;
Khan H, Aziz AA, Sulahria H, Khan H, Ahmed A, Choudhry N, Narayanan R, Danzig C, Khanani AM   +8 more
doaj  

Neuroproteção no acidente vascular celebral: opinião nacional Neuroprotective agents in stroke: national opinion

Arquivos de Neuro-Psiquiatria, 2005
Com finalidade de orientar e oferecer subsídios para a conduta diagnóstica e terapêutica em diferentes situações dentro das doenças cerebrovasculares, a Sociedade Brasileira de Doenças Cerebrovasculares (SBDCV) constituiu um comitê composto por ...
Gabriel R. de Freitas, Jorge El Kadum Noujaim, Sérgio R. Haussen, Fábio I. Yamamoto, Edson M. Novak, Rubens J. Gagliardi   +5 more
doaj   +1 more source

Cyclosporine A as a potential neuroprotective agent: a study of prolonged hypothermic circulatory arrest in a chronic porcine model [PDF]

, 2001
Christian Hagl, Nadine Tatton, Donald J. Weisz, Ning Zhang, David Spielvogel, Howard Shiang, Carol Bodian, Randall B. Griepp   +7 more
openalex   +1 more source

Some Novel Therapies in Parkinson’s Disease: A Promising Path Forward or Not Yet? A Systematic Review of the Literature

Biomedicines
In light of the unsuccessful traditional therapies for Parkinson’s disease (PD) overmany years, there is an unmet need for the development of novel therapies to alleviate the symptoms of PD retardation or halt the progression of the disease itself.
Anastasia Bougea
doaj   +1 more source

The Feasibility of Neuroprotective Agent Administration by Pre-hospital Personnel in an Urban Setting [PDF]

, 2001
Todd J. Crocco, Travis C Gullett, Edward C. Jauch, Richard Hornung, Thomas C. Chenier   +4 more
openalex   +1 more source

Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a neuroprotective agent [PDF]

, 2002
Peter J. Hutchinson, Mark T. O’Connell, Jonathan Coles, D. A. Chatfield, M. R. Coleman, Pippa G. Al-Rawi, C. R. Kett‐White, Arun Gupta, DK Menon, Simon Boniface, M. Heazell, Peter J. Kirkpatrick, John D. Pickard   +12 more
openalex   +1 more source

Neuroprotective and Antiepileptic Activities of Ketamine in Nerve Agent Poisoning [PDF]

, 2003
Avi A. Weinbroum
openalex   +1 more source

Additive effects of combination treatment with anti-inflammatory and neuroprotective agents in experimental autoimmune encephalomyelitis [PDF]

, 2009
Sienmi Du, Francisco Sandoval, Pauline Trinh, Rhonda R. Voskuhl   +3 more
openalex   +1 more source

Nature's weapons: Bioactive compounds as anti-cancer agents

AIMS Public Health
Cancer represents a major global health burden, prompting continuous research for effective therapeutic strategies. Natural compounds derived from plants have emerged as potential strategies for preventing cancer and treatment because of their inherent ...
Amogh Auti, Madhura Tathode, Maria Michela Marino, Antonio Vitiello , Andrea Ballini , Francesco Miele, Valeria Mazzone, Alessia Ambrosino , Mariarosaria Boccellino   +8 more
doaj   +1 more source